Research from Atrium Research, Atrium Research Corporation

Atrium Research

Atrium Research provides institutional quality issuer paid research on public equities in North America. Our investment philosophy takes a 3-5 year view on equities currently being overlooked by the market. Our research process emphasizes understanding the key performance metrics for each specific company, trustworthy management teams, unit economics, and an in-depth valuation analysis.

Our research product includes in-depth initiation reports, research notes, thematic research pieces, and company fact sheets.

Research from Atrium Research

Atrium Research Corporation

Atrium Research provides institutional quality issuer paid research on public equities in North America. Our investment philosophy takes a 3-5 year view on equities currently being overlooked by the market. Our research process emphasizes understanding the key performance metrics for each specific company, trustworthy management teams, unit economics, and an in-depth valuation analysis. 

Our research product includes in-depth initiation reports, research notes, thematic research pieces, and company fact sheets.

Equity Bottom-Up

<ul>
<li>Amerigo reported Q4 and 2025 financial results, generating revenue of $79.8M (+57% YoY) and $227.3M (+18% YoY) vs. our expectation of $70.2M and $217.7M, respectively.</li>
<li>EBITDA was $38.1M vs. our $30.1M estimate in Q4 and $89.9M (+31% YoY) in 2025.</li>
<li>OCF was $24.6M in Q4 and $60.5M in 2025.</li>
</ul>


Amerigo reported Q4 and 2025 financial results, generating revenue of $79.8M (+57% YoY) and $227.3M (+18% YoY) vs. our expectation of $70.2M and $217.7M, respectively.
EBITDA was $38.1M vs. our $30.1M estimate in Q4 and $89.9M (+31% YoY) in 2025.
OCF was $24.6M in Q4 and $60.5M in 2025.


ARG: 好調な執行により目標価格を引き上げ

Amerigo Resources

ARG: 好調な執行により目標価格を引き上げ